AU2001229722A1 - Inhibitors of thrombin induced platelet aggregation - Google Patents

Inhibitors of thrombin induced platelet aggregation

Info

Publication number
AU2001229722A1
AU2001229722A1 AU2001229722A AU2972201A AU2001229722A1 AU 2001229722 A1 AU2001229722 A1 AU 2001229722A1 AU 2001229722 A AU2001229722 A AU 2001229722A AU 2972201 A AU2972201 A AU 2972201A AU 2001229722 A1 AU2001229722 A1 AU 2001229722A1
Authority
AU
Australia
Prior art keywords
inhibitors
platelet aggregation
induced platelet
thrombin induced
thrombin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229722A
Inventor
Fatih M. Uckun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parker Hughes Institute
Original Assignee
Parker Hughes Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/042345 external-priority patent/WO2001045641A2/en
Application filed by Parker Hughes Institute filed Critical Parker Hughes Institute
Publication of AU2001229722A1 publication Critical patent/AU2001229722A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
AU2001229722A 2000-11-29 2001-01-23 Inhibitors of thrombin induced platelet aggregation Abandoned AU2001229722A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2000/042345 WO2001045641A2 (en) 1999-11-30 2000-11-29 Inhibitors of thrombin induced platelet aggregation
WOUS00/42345 2000-11-29
PCT/US2001/002195 WO2002043735A1 (en) 2000-11-29 2001-01-23 Inhibitors of thrombin induced platelet aggregation

Publications (1)

Publication Number Publication Date
AU2001229722A1 true AU2001229722A1 (en) 2002-06-11

Family

ID=21742210

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229722A Abandoned AU2001229722A1 (en) 2000-11-29 2001-01-23 Inhibitors of thrombin induced platelet aggregation

Country Status (2)

Country Link
AU (1) AU2001229722A1 (en)
WO (1) WO2002043735A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
DK1534286T3 (en) 2002-07-29 2010-04-26 Rigel Pharmaceuticals Inc Methods for treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
CN1849318B (en) 2003-07-30 2011-10-12 里格尔药品股份有限公司 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
US7491732B2 (en) 2005-06-08 2009-02-17 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
US20070203161A1 (en) 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
WO2007098507A2 (en) 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
PL2265607T3 (en) 2008-02-15 2017-07-31 Rigel Pharmaceuticals, Inc. Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
US8138339B2 (en) 2008-04-16 2012-03-20 Portola Pharmaceuticals, Inc. Inhibitors of protein kinases
BRPI0910921B1 (en) 2008-04-16 2022-06-21 Portola Pharmaceuticals, Inc Syk kinase protein inhibitors, pharmaceutical composition, kit and uses of said inhibitors
CA2723185A1 (en) 2008-04-22 2009-10-29 Portola Pharmaceuticals, Inc. Inhibitors of protein kinases
US9102625B2 (en) 2010-11-01 2015-08-11 Portola Pharmaceuticals, Inc. Nicotinamides as JAK kinase modulators
US8877760B2 (en) 2011-11-23 2014-11-04 Portola Pharmaceuticals, Inc. Substituted pyrazine-2-carboxamide kinase inhibitors
EP2903970A4 (en) 2012-10-08 2016-11-30 Portola Pharm Inc Substituted pyrimidinyl kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3800039A (en) * 1970-10-21 1974-03-26 Mead Johnson & Co Antithrombogenic process employing substituted 6,7-dialkoxyquinazolines
JP2657760B2 (en) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4-aminoquinazoline derivatives and pharmaceuticals containing them
GB9624482D0 (en) * 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
PT885198E (en) * 1996-03-05 2002-06-28 Astrazeneca Ab 4-ANYLINOQUINAZOLINE DERIVATIVES

Also Published As

Publication number Publication date
WO2002043735A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2002213485A1 (en) Inhibitors of protein kinases
AU2001258771A1 (en) -secretase inhibitors
AU2001249399A1 (en) Isoquinolone inhibitors of factor xa
AU2001229722A1 (en) Inhibitors of thrombin induced platelet aggregation
AU1624801A (en) Plasminogen activator inhibitor antagonists related applications
AU2001243158A1 (en) Inhibitors of prenyl-protein transferase
GB0025782D0 (en) Use of inhibitors
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
AU2001294557A1 (en) Thrombin inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU6379101A (en) Highly selective inhibitors of the urokinase plasminogen activator
AU2001238217A1 (en) Inhibitors of prenyl-protein transferase
AU2001247197A1 (en) Inhibitors of prenyl-protein transferase
AU2002322802A1 (en) Thrombin inhibitors
AU2001227757A1 (en) Inhibitors of prenyl-protein transferase
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
IL152396A0 (en) New thiochromane derivatives derivatives and their use as thrombin inhibitors
AU2001238424A1 (en) Inhibitors of prenyl-protein transferase
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2001230864A1 (en) Inhibitors of prenyl-protein transferase
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2001255408A1 (en) Tetrahydro-azepinone derivatives as thrombin inhibitors
AU2002222933A1 (en) Inhibitors of factor xa
AU2002351076A1 (en) Thrombin inhibitors